TD-1473 Absorption, Distribution, Metabolism and Excretion (ADME) Study in Healthy Male Subjects
Status:
Completed
Trial end date:
2018-02-21
Target enrollment:
Participant gender:
Summary
This is an open-label, 2-cohort study to evaluate the absolute bioavailability, absorption,
distribution, metabolism and excretion of TD-1473 in healthy male subjects. Subjects in
cohort 1 will receive a single oral dose of TD-1473 and a single intravenous bolus dose of
[14C]-TD-1473. Subjects in cohort 2 will receive a single oral dose of [14C]-TD-1473 only.